Corlieve Therapeutics
Entity

  • Corlieve Therapeutics

    Created in 2019
  • BETA

    To investigate (B)
    Some signals may appear as inconsistent with a regular activity

  • Social networks

    932

  • Activities

    deeptech biotech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    Paris, France

    Paris

    France

  • Employees

    Scale: 11-50

    Estimated: 2

  • Engaged corporates

    2
    2 0

  • Added in Motherbase

    7 months, 2 weeks ago
Description
  • Value proposition

    At Corlieve, we are focused on bringing novel therapeutic options to patients with severe neurological disorders.

    Corlieve Therapeutics, a fully owned subsidiary of UniQure, is a biotechnology company focused on bringing novel therapeutic options to patients with severe neurological disorders.

Corporate interactions BETA
Corporate TypeTweets Articles
Eurazeo
Eurazeo
Finance, Financial Services
Eurazeo
Finance, Financial Services 		Other

29 Oct 2022


SATT Aquitaine Science Transfert
SATT Aquitaine Science Transfert
SATT Aquitaine Science Transfert
Other

6 Feb 2024


Similar entities
Last news
Show all articles
Social network dynamics